Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Harvard Business School
AstraZeneca
Mallinckrodt
Johnson and Johnson

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Athenex Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ATHENEX INC, and what generic and branded alternatives to ATHENEX INC drugs are available?

ATHENEX INC has fifteen approved drugs.



Summary for Athenex Inc
US Patents:0
Tradenames:13
Ingredients:12
NDAs:15

Drugs and US Patents for Athenex Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc BUMETANIDE bumetanide INJECTABLE;INJECTION 074441-001 Jan 27, 1995 DISCN No No   Start Trial   Start Trial
Athenex Inc ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074596-002 Apr 22, 1997 DISCN No No   Start Trial   Start Trial
Athenex Inc DIPYRIDAMOLE dipyridamole INJECTABLE;INJECTION 074939-001 Apr 13, 1998 AP RX No Yes   Start Trial   Start Trial
Athenex Inc TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076770-001 Apr 23, 2004 AP RX No Yes   Start Trial   Start Trial
Athenex Inc DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 076266-001 Jan 10, 2003 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Johnson and Johnson
McKesson
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.